AllianceBernstein’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.8M | Sell |
556,151
-42,737
| -7% | -$2.22M | 0.01% | 819 |
|
|
2026
Q1 | $24.7M | Buy |
598,888
+270,614
| +82% | +$12M | 0.01% | 830 |
|
|
2025
Q4 | $13.5M | Buy |
+328,274
| New | +$13.2M | ﹤0.01% | 1117 |
|
|
2025
Q2 | – | Sell |
-39,560
| Closed | -$879K | – | 3278 |
|
|
2025
Q1 | $879K | Hold |
39,560
| – | – | ﹤0.01% | 2304 |
|
|
2024
Q4 | $782K | Hold |
39,560
| – | – | ﹤0.01% | 2439 |
|
|
2024
Q3 | $989K | Buy |
+39,560
| New | +$964K | ﹤0.01% | 2336 |
|
|
2024
Q2 | – | Sell |
-39,560
| Closed | -$781K | – | 3268 |
|
|
2024
Q1 | $781K | Hold |
39,560
| – | – | ﹤0.01% | 2392 |
|
|
2023
Q4 | $694K | Sell |
39,560
-2,340
| -6% | -$38.5K | ﹤0.01% | 2448 |
|
|
2023
Q3 | $728K | Hold |
41,900
| – | – | ﹤0.01% | 2381 |
|
|
2023
Q2 | $590K | Hold |
41,900
| – | – | ﹤0.01% | 2546 |
|
|
2023
Q1 | $451K | Hold |
41,900
| – | – | ﹤0.01% | 2614 |
|
|
2022
Q4 | $628K | Hold |
41,900
| – | – | ﹤0.01% | 2511 |
|
|
2022
Q3 | $538K | Buy |
41,900
+5,700
| +16% | +$64.9K | ﹤0.01% | 2611 |
|
|
2022
Q2 | $351K | Buy |
36,200
+6,200
| +21% | +$57.9K | ﹤0.01% | 2827 |
|
|
2022
Q1 | $298K | Buy |
30,000
+100
| +0.3% | +$1.06K | ﹤0.01% | 2873 |
|
|
2021
Q4 | $352K | Buy |
29,900
+1,000
| +3% | +$12.3K | ﹤0.01% | 2892 |
|
|
2021
Q3 | $329K | Sell |
28,900
-3,700
| -11% | -$48.2K | ﹤0.01% | 2928 |
|
|
2021
Q2 | $454K | Buy |
32,600
+10,600
| +48% | +$161K | ﹤0.01% | 2850 |
|
|
2021
Q1 | $407K | Sell |
22,000
-7,700
| -26% | -$157K | ﹤0.01% | 2762 |
|
|
2020
Q4 | $525K | Buy |
29,700
+1,400
| +5% | +$24.6K | ﹤0.01% | 2565 |
|
|
2020
Q3 | $434K | Sell |
28,300
-1,200
| -4% | -$22.5K | ﹤0.01% | 2595 |
|
|
2020
Q2 | $752K | Buy |
29,500
+3,600
| +14% | +$75.2K | ﹤0.01% | 2359 |
|
|
2020
Q1 | $401K | Buy |
25,900
+6,700
| +35% | +$105K | ﹤0.01% | 2464 |
|
|
2019
Q4 | $212K | Hold |
19,200
| – | – | ﹤0.01% | 2902 |
|
|
2019
Q3 | $163K | Buy |
19,200
+5,300
| +38% | +$58.6K | ﹤0.01% | 2989 |
|
|
2019
Q2 | $188K | Buy |
+13,900
| New | +$216K | ﹤0.01% | 2984 |
|
|
2019
Q1 | – | Sell |
-8,800
| Closed | -$247K | – | 3131 |
|
|
2018
Q4 | $247K | Buy |
+8,800
| New | +$184K | ﹤0.01% | 2811 |
|
Other funds holding KNSA
RCMNY
BBA
TCM
SSC
AllianceBernstein's KNSA Position: Q2 2026 in Review
AllianceBernstein reduced its Kiniksa Pharmaceuticals (KNSA) stake by 7.1% in Q2 2026, selling an estimated $2.22M and leaving 556,151 shares worth $26.8M. The position accounts for 0.01% of the portfolio, ranked #819.
AllianceBernstein first reported a position in KNSA in Q4 2018 and has held it in 27 quarters since. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.
- AllianceBernstein held 556,151 shares of Kiniksa Pharmaceuticals worth $26.8M as of Q2 2026.
- AllianceBernstein sold 42,737 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $2.22M.
- Kiniksa Pharmaceuticals made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #819 holding.
- AllianceBernstein first reported a position in Kiniksa Pharmaceuticals in Q4 2018 and has held it in 27 quarters since.
- 267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.